|
21 Companies |
|
21 Products |
|
21 Products |
|
143 Mechanisms of Action |
|
1 Trial |
|
106 News |
|
| «123» |
- ||| ISC 17536 / Glenmark
Enrollment closed, Trial primary completion date: A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). (clinicaltrials.gov) - Jul 1, 2014
P2, N=138, Active, not recruiting, Sponsor: Glenmark Pharmaceuticals Ltd. India
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Aug 2014
- | New P1/2 trial: SINF: Peripheral Neuropathy in Cancer Survivors (clinicaltrials.gov) - Jun 22, 2014
P1/2, N=120, Not yet recruiting, Sponsor: M.D. Anderson Cancer Center
- Clinical: The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Apr 28, 2014
P=N/A, N=110, Recruiting, Sponsor: Ottawa Hospital Research Institute
- HEOR: DPN-QoL: Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=260, Not yet recruiting, Sponsor: National University Health System, Singapore
- ||||||| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
Trial completion: PACE: A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients (clinicaltrials.gov) - Mar 25, 2014
P3, N=468, Completed, Sponsor: Astellas Pharma Inc
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Aug 2014 Active, not recruiting --> Completed
- ||||||| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
Trial completion: A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) (clinicaltrials.gov) - Mar 12, 2014
P3, N=369, Completed, Sponsor: Astellas Pharma Inc
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ASP8477 / Astellas
Enrollment open: A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety (clinicaltrials.gov) - Feb 26, 2014
P2, N=150, Recruiting, Sponsor: Astellas Pharma Europe B.V.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
Trial completion: Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: NeurogesX
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- ||||||| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
Trial completion: Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia (clinicaltrials.gov) - Feb 22, 2014
P3, N=150, Completed, Sponsor: NeurogesX
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
Trial completion: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (clinicaltrials.gov) - Feb 22, 2014
P3, N=300, Completed, Sponsor: NeurogesX
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
Trial completion: NGX-4010 for the Treatment of Postherpetic Neuralgia (clinicaltrials.gov) - Feb 22, 2014
P2/3, N=300, Completed, Sponsor: NeurogesX
No longer recruiting --> Completed No longer recruiting --> Completed
- | amifostine / Generic mfg.
Trial completion: Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=100, Completed, Sponsor: Gynecologic Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Marijuana for HIV-Related Peripheral Neuropathy (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=50, Completed, Sponsor: Center for Medicinal Cannabis Research
Active, not recruiting --> Completed Recruiting --> Completed
- | ASP8477 / Astellas
New P2 trial: A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety (clinicaltrials.gov) - Feb 17, 2014
P2, N=150, Recruiting, Sponsor: Astellas Pharma Europe B.V.
- |||| CNV2197944 / Biogen
Enrollment open: Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Jan 6, 2014
P2, N=165, Recruiting, Sponsor: Convergence Pharmaceuticals
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Dec 12, 2013
P=N/A, N=50, Completed, Sponsor: University of Michigan
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Clinical: Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy (clinicaltrials.gov) - Nov 11, 2013
P=N/A, N=113, Recruiting, Sponsor: Fox Chase Cancer Center
- |||| Trial completion: Study of Metanx (clinicaltrials.gov) - Jul 25, 2013
P4, N=214, Completed, Sponsor: Pamlab, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative Study (clinicaltrials.gov) - Jul 7, 2013
P=N/A, N=40, Completed, Sponsor: Haukeland University Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- ||||| CNV2197944 / Biogen
New P2 trial: Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Jul 4, 2013
P2, N=165, Recruiting, Sponsor: Convergence Pharmaceuticals
- | Trial completion: Acupuncture for Chemo-Induced Peripheral Neuropathy (clinicaltrials.gov) - Apr 8, 2013
P2, N=27, Completed, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed
- bortezomib / Generic mfg.
Trial withdrawal: Chemotherapy-Induced Peripheral Neuropathy Survey (clinicaltrials.gov) - Feb 17, 2013
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Recruiting --> Withdrawn
- bortezomib / Generic mfg.
Enrollment change: Chemotherapy-Induced Peripheral Neuropathy Survey (clinicaltrials.gov) - Feb 17, 2013
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Withdrawn N=200 --> 0
- Enrollment change: Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=39, Completed, Sponsor: Virginia Commonwealth University
N=200 --> 0 N=100 --> 39
- Trial completion: Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=39, Completed, Sponsor: Virginia Commonwealth University
N=100 --> 39 Recruiting --> Completed
- | olesoxime (TRO19622) / Roche
Enrollment change: CIPN: Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy (clinicaltrials.gov) - Dec 26, 2012
P2, N=17, Completed, Sponsor: Trophos
Recruiting --> Completed N=40 --> 17
- | olesoxime (TRO19622) / Roche
Trial completion: CIPN: Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy (clinicaltrials.gov) - Dec 26, 2012
P2, N=17, Completed, Sponsor: Trophos
N=40 --> 17 Recruiting --> Completed
- |||| ISC 17536 / Glenmark
Enrollment open: A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). (clinicaltrials.gov) - Dec 12, 2012
P2, N=138, Recruiting, Sponsor: Glenmark Pharmaceuticals Ltd. India
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=46, Completed, Sponsor: Texas Woman's University
Not yet recruiting --> Recruiting N=88 --> 46
- Trial completion: Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=46, Completed, Sponsor: Texas Woman's University
N=88 --> 46 Recruiting --> Completed
- ||||| ISC 17536 / Glenmark
New P2 trial: A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). (clinicaltrials.gov) - Nov 12, 2012
P2, N=138, Recruiting, Sponsor: Glenmark Pharmaceuticals Ltd. India
- Trial completion: Treatment Trial Using Low Level Laser Therapy (LLLT) for Treatment of Chemotherapy Induced Peripheral Neuropathy (clinicaltrials.gov) - Oct 16, 2012
P=N/A, N=20, Completed, Sponsor: Legacy Health System
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Effect of Exercise on Gait and Balance in Peripheral Neuropathy (clinicaltrials.gov) - Oct 2, 2012
P=N/A, N=165, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Active, not recruiting --> Completed
- ||| bortezomib / Generic mfg.
Clinical: Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients (clinicaltrials.gov) - Sep 30, 2012
P=N/A, N=110, Recruiting, Sponsor: Oncotherapeutics
- paclitaxel / Generic mfg.
Trial initiation date: Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy (clinicaltrials.gov) - Aug 8, 2012
P1/2, N=30, Recruiting, Sponsor: Northwestern University
Active, not recruiting --> Completed Initiation date: Jul 2011 --> Feb 2012
- paclitaxel / Generic mfg.
Enrollment open: Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy (clinicaltrials.gov) - Aug 8, 2012
P1/2, N=30, Recruiting, Sponsor: Northwestern University
Initiation date: Jul 2011 --> Feb 2012 Not yet recruiting --> Recruiting
- Trial completion: IIDPN;UCALG-IIDPN: Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Aug 8, 2012
P2a, N=12, Completed, Sponsor: University of Calgary
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial termination: Near Infrared Light for the Treatment of Painful Peripheral Neuropathy (clinicaltrials.gov) - Aug 1, 2012
P3, N=30, Terminated, Sponsor: Mayo Clinic
Recruiting --> Completed Completed --> Terminated; Unable to enroll enough patients
- Enrollment change: Near Infrared Light for the Treatment of Painful Peripheral Neuropathy (clinicaltrials.gov) - Aug 1, 2012
P3, N=30, Terminated, Sponsor: Mayo Clinic
Completed --> Terminated; Unable to enroll enough patients N=60 --> 30
- ||| Trial completion: Administrative Claims Analysis of Metanx (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=500, Completed, Sponsor: Pamlab, L.L.C.
N=60 --> 30 Recruiting --> Completed
- bortezomib / Generic mfg., thalidomide / Generic mfg.
New P2 trial: Acupuncture for Peripheral Neuropathy (clinicaltrials.gov) - Jul 2, 2012
P2, N=40, Recruiting, Sponsor: Singapore General Hospital
- Enrollment change: Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy (clinicaltrials.gov) - Jun 18, 2012
P2, N=18, Completed, Sponsor: Virginia Commonwealth University
Recruiting --> Completed N=15 --> 18
- Trial completion: Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy (clinicaltrials.gov) - Jun 18, 2012
P2, N=18, Completed, Sponsor: Virginia Commonwealth University
N=15 --> 18 Not yet recruiting --> Completed
- amitriptyline / Generic mfg.
Trial completion: The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients (clinicaltrials.gov) - Mar 29, 2012
P=N/A, N=260, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Completed Active, not recruiting --> Completed
- Clinical: Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=36, Completed, Sponsor: George Mason University
- |||||||||| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems
New P3 trial: A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) (clinicaltrials.gov) - Feb 13, 2012
P3, N=369, Completed, Sponsor: Astellas Pharma Inc
- oxaliplatin / Generic mfg.
New P2 trial: Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis (clinicaltrials.gov) - Dec 18, 2011
P2, N=38, Completed, Sponsor: Felipe Melo Cruz
- ||||| carboplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment closed: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer (clinicaltrials.gov) - Dec 12, 2011
P3, N=186, Active, not recruiting, Sponsor: North Central Cancer Treatment Group
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Disalcid (salsalate) / Bausch Health
Enrollment closed: Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy (clinicaltrials.gov) - Dec 1, 2011
P2, N=10, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Disalcid (salsalate) / Bausch Health
New P2 trial: Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy (clinicaltrials.gov) - Nov 24, 2011
P2, N=10, Active, not recruiting, Sponsor: University of Michigan